America’s Billionaires Set Out to Create Non-Profit Healthcare

Patrick Watson |

Images via Wikimedia/Flickr CC/Wikimedia

Last week, three top CEOs said they will radically transform health care for their own employees—and perhaps for the entire United States.

Every American adult knows health care is ridiculously expensive. You pay through the nose for insurance premiums and even more for the deductible if you happen to get sick.

Alternatively, your employer pays and recovers the cost through lower salaries. Plus, you probably pay income tax and Medicare tax.

Can billionaires save us from medical bankruptcy? I’m not holding my breath. However, their idea has a new twist. And considering who came up with it, we’d best pay attention.

Bezos, Buffett, and Dimon to Save Health Care

A January 30 CNN report stated:

Can Jeff Bezos, Warren Buffett and Jamie Dimon fix health care?

Amazon (AMZN) is partnering with Buffett’s Berkshire Hathaway (BRK.A) and JPMorgan Chase (JPM), the nation’s largest bank, to try to address one of the nation’s thorniest and priciest problems—soaring health care costs.

The three companies unveiled an as yet unnamed company to give their U.S. workers and families a better option on health insurance. The statement said the new company will be “free from profit-making incentives and constraints.”

“The ballooning costs of health care act as a hungry tapeworm on the American economy,” said Buffett. “We share the belief that putting our collective resources behind the country’s best talent can, in time, check the rise in health costs while concurrently enhancing patient satisfaction and outcomes.”

They are right. We spend far more money on health care than other developed countries. And it buys results no better—and in some ways worse—than theirs.

Take a look at the chart below. The blue bars are the percentage of GDP each country spends on health care. The gray bars are life expectancy.


Photo: World Economic Forum

The US is on the far right.

We devote twice as much of our economic output to health care than any of the others. Yet average US life expectancy is below that of 20 other countries, including Greece, Slovenia, Korea, Italy, and Israel.

While there’s disagreement on the causes and solutions, surely we can all agree this is bananas.

We misallocate trillions of dollars that could go to much better uses, depressing growth and wasting human capital. As macroeconomic problems go, this is a big one.

Bezos, Buffett, and Dimon think they can solve the problem. I wish them luck. Many smart people have tried and failed.

Non-Profit Health Care

An old saying about advertising says half the money is wasted, but no one knows which half. The same might apply to medical spending.

It seems that much of this money makes us no healthier. For instance, last week the Wall Street Journal reported on an effort to reduce chemotherapy treatment for breast cancer patients.



“Tens of thousands of women were over-treated, they got surgery they didn’t need, they got radiation they didn’t need, and they got chemotherapy they didn’t need,” says Steven Katz, a professor of medicine at the University of Michigan.

If Dr. Katz is right about chemotherapy being overused, it means patients and their employers/insurers spent billions on painful, unnecessary treatment.

The only ones benefitting appear to be the chemotherapy drug makers, the doctors who prescribe them, and all the associated providers.

Bezos, Buffett, and Dimon seem to get this part.

Their news release says they will try to reduce costs “through an independent company that is free from profit-making incentives and constraints.”

The three billionaire business leaders, who know a lot about profit, think health care will work better if they free it from profit motives.

Those are fighting words for free-market advocates. In their view, the profit motive is good because it efficiently maximizes everyone’s desires, and I think that’s usually true too.

However, Bezos, Buffett, and Dimon appear to think health care is an exception.

Drug Profit Margins

Big-name healthcare companies are highly profitable—more so than Amazon, Berkshire Hathaway, or JPMorgan Chase.

Here’s a chart comparing their profit margins.


Graphic: Milton Financial Markets Research Institute

The highest profits are generated by Big Pharma. Gilead (GILD) has a margin of almost 45%, and some others aren’t far behind.

In comparison, Amazon has a tiny 1.7% margin, which is enough to make Jeff Bezos the world’s richest man. In all fairness, though, Amazon’s is a different business than health care.

Arguably the drug companies should be rewarded because they take huge risks in developing drugs that may not work, and many fail.

But this isn’t capitalism.

Those profit margins are huge mainly because taxpayers provide much of the basic research the companies use, and intellectual property laws protect them from competition.

Their political muscle prohibits Medicare from negotiating price discounts, even though it is their biggest customer.

Those are some of the incentives I think Bezos, Buffett, and Dimon want to eliminate—exactly how is unclear, but they intend to try. They’ve concluded health care can’t work like a normal business.

But it’s not so simple as just making everything non-profit. Much of the healthcare sector already is. VA hospitals are non-profit and have huge problems.

Many “charity” hospital executives earn huge paychecks for maximizing revenue and minimizing costs, even if the bottom line shows a nominal loss.

If we don’t let profit be the motivator, something better must take its place, but so far it’s not clear what that would be, or how the US could transition to it.

Nevertheless, the problem seems to be clear. When revenue and profits become the primary goals, and customers can’t easily go elsewhere, prices spiral upward—and here we are. The US spends more than other countries because our system is built on massive profit incentives.

Now, fixing this will be hard because the same money you or I might consider “waste” represents someone else’s paycheck or profit margin. The Three Amigos have their work cut out for them.

Many experts are dubious this effort will work any better than past ones. Maybe not, but if they succeed, the US healthcare industry could look radically different a decade from now.

So, if you’re a healthcare investor who expects to make long-term profits, you probably should keep your eye on this.

Free Report: The New Asset Class Helping Investors Earn 7% Yields in a 2.5% World

While the Fed may be raising interest rates, the reality is we still live in a low-yield world. This report will show you how to start earning market-beating yields in as little as 30 days... and simultaneously reduce your portfolio’s risk exposure.

Claim your free copy here.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
GILD Gilead Sciences Inc. 80.70 -0.85 -1.04 7,548,648 Trade
JPM JP Morgan Chase 114.68 -0.83 -0.72 13,214,253 Trade
AMZN Amazon.com Inc. 1,448.69 -13.07 -0.89 4,472,564 Trade
BRK.A Berkshire Hathaway Inc. Cl A 306,000.00 1.01 0.00 367 Trade

Comments

Emerging Growth

NXT-ID Inc.

Nxt-ID Inc provides products, solutions, and services that have a need for biometric secure access control. Its lines of business include mobile commerce; law enforcement and biometric access control applications…

Private Markets

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.